Improving cancer screening and prevention in diverse populations
HFH-MSU CSRN ACCrual Enrollment and Screening Site
['FUNDING_OTHER'] · HENRY FORD HEALTH + MICHIGAN STATE UNIVERSITY HEALTH SCIENCES · NIH-11035148
This study is working to improve cancer screening and prevention by teaming up with local health experts to find and support people at risk, especially in diverse communities, so they can get the care they need early on.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | HENRY FORD HEALTH + MICHIGAN STATE UNIVERSITY HEALTH SCIENCES (nih funded) |
| Locations | 1 site (EAST LANSING, UNITED STATES) |
| Trial ID | NIH-11035148 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing cancer screening and prevention efforts through a collaborative approach between Henry Ford Health and Michigan State University. It aims to identify and engage at-risk populations using electronic health records, ensuring effective recruitment and long-term follow-up for participants. The project builds on over 20 years of experience in conducting multi-site cancer trials, with a particular emphasis on serving racially and socioeconomically diverse communities. By leveraging past successes in major cancer screening trials, this initiative seeks to improve early detection and treatment outcomes for various cancers.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals from racially and socioeconomically diverse backgrounds who are at risk for advanced cancers.
Not a fit: Patients who are not at risk for cancer or who do not belong to the targeted demographic groups may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer detection rates and better health outcomes for patients in underserved communities.
How similar studies have performed: Previous research has shown success in similar cancer screening approaches, particularly in diverse populations, indicating a strong potential for impactful outcomes.
Where this research is happening
EAST LANSING, UNITED STATES
- HENRY FORD HEALTH + MICHIGAN STATE UNIVERSITY HEALTH SCIENCES — EAST LANSING, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: NESLUND-DUDAS, CHRISTINE MARIE — HENRY FORD HEALTH + MICHIGAN STATE UNIVERSITY HEALTH SCIENCES
- Study coordinator: NESLUND-DUDAS, CHRISTINE MARIE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Advanced Cancer